SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $201,000 | -69.5% | 19,694 | -67.2% | 0.03% | +55.6% |
| Q4 2019 | $660,000 | +59.0% | 60,008 | +31.4% | 0.02% | +80.0% |
| Q3 2019 | $415,000 | +50.4% | 45,660 | +88.5% | 0.01% | +66.7% |
| Q2 2019 | $276,000 | -39.5% | 24,223 | -39.5% | 0.01% | -40.0% |
| Q1 2019 | $456,000 | -8.2% | 40,013 | -27.3% | 0.01% | -23.1% |
| Q4 2018 | $497,000 | -58.6% | 55,068 | -31.0% | 0.01% | -48.0% |
| Q3 2018 | $1,201,000 | – | 79,856 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |